Results

1–10 of 31 results for Steroids

Outcomes of Eyes Lost to Follow-up After Treatment With Intraocular and Periocular Steroid Injections
John W Hinkle, MD
On Demand Cases, Courses, and Papers
2021
Efficacy and Safety of ‘Dropless Vitrectomy Surgery’ and Comparison of Outcomes to Standard of Care Topical Therapy
K. V. Chalam, MD, PhD, MBA, FRCS(C), FASRS
Annual Meeting Talks
2021
Evaluating the True 3-Year Recurrence Rate in Non-infectious Posterior Segment Uveitis following an Injectable Fluocinolone Acetonide Insert
Dilraj S Grewal, MD, FASRS
Annual Meeting Talks
2020
Variability of Retinal Thickness in Diabetic macular edema (DME) Patients Treated with 0.19mg Fluocinolone Acetonide (FAc, ILUVIEN).
Christopher D. Riemann, MD
On Demand Cases, Courses, and Papers
2019
Interim 12-Month Results from PALADIN in Diabetic Macular Patients Receiving ILUVIEN: Analysis of the Prior Dexamethasone Cohort
Daniel F. Kiernan, MD, FACS
On Demand Cases, Courses, and Papers
2019
Wet AMD 7 Symposium
Annual Meeting Talks
2020
Diabetic Retinopathy Progression in Anti-VEGF versus Fluocinolone Acetonide Implant Treated Eyes Who are Lost to Follow-up
Caesar K. Luo, MD, FASRS
Updates from the Field
2020
Suprachoroidal CLS-TA Improves Patient Outcomes in Uveitis of All Anatomic Subtypes: Results of the Phase 3 PEACHTREE Study
Christopher R Henry, MD
Updates from the Field
2019
Inflammatory and Infectious Diseases Take-Home Panel
Sunil Srivastava, MD
Annual Meeting Talks
2019
Suprachoroidally Injected CLS-TA in Uveitis Maintains Efficacy Outcomes Through 48 Weeks
Pauline T. Merrill, MD, FASRS
Annual Meeting Talks
2019